Human Lung Adenocarcinoma Cells: control vs. mAb NJ001 treated
收藏官方服务：
资源简介：
Human Lung Adenocarcinoma Cells: control vs. mAb NJ001 treated
应用场景：
创建时间：
2014-08-01
相关数据集
surrogate responses and sotrovimab
- accessions_metadata_nopatid.tsv contains the accession id, the day and treatment information - counts.tsv contains the tpm (transcripts per million) matrix for the respective accession ids.
Figshare2022-07-17 更新100
Guselkumab (interleukin-23-specific monoclonal antibody) demonstrates clinical and molecular response in moderate-to-severe psoriasis
Guselkumab (interleukin-23-specific monoclonal antibody) demonstrates clinical and molecular response in moderate-to-severe psoriasis
ChEBI2014-05-14 更新30
Data_Sheet_1_Measuring the impact of monoclonal antibody therapies.pdf
ObjectiveMonoclonal antibody (Mab) treatments have significantly improved the quality and quantity of life, but they are some of the most expensive treatments, resulting in a degree of hesitancy to in
NIAID Data Ecosystem10
Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice
Epidemic methicillin-resistant Staphylococcus aureus (MRSA) imposes an increasing impact on public health. Due to multi-antibiotics resistance in MRSA strains, there is an urgent need to develop novel
NIAID Data Ecosystem60
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a non-human primate model
Monoclonal antibodies are a powerful tool for the prophylaxis and treatment of acute viral infections. Hence, they were one of the first therapeutic agents licensed for the treatment of SARS-CoV-2. Of
NIAID Data Ecosystem10
